Seldon Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$419K Hold
1,713
0.15% 44
2025
Q4
$355K Hold
1,713
0.12% 49
2025
Q3
$318K Hold
1,713
0.11% 54
2025
Q2
$262K Hold
1,713
0.11% 55
2025
Q1
$284K Hold
1,713
0.18% 48
2024
Q4
$248K Hold
1,713
0.1% 58
2024
Q3
$278K Hold
1,713
0.16% 50
2024
Q2
$250K Hold
1,713
0.14% 51
2024
Q1
$271K Hold
1,713
0.16% 48
2023
Q4
$268K Hold
1,713
0.19% 44
2023
Q3
$267K Hold
1,713
0.23% 40
2023
Q2
$284K Sell
1,713
-1,713
-50% -$276K 0.26% 39
2023
Q1
$531K Buy
3,426
+1,713
+100% +$277K 0.26% 38
2022
Q4
$303K Hold
1,713
0.26% 33
2022
Q3
$280K Hold
1,713
0.2% 39
2022
Q2
$304K Hold
1,713
0.18% 42
2022
Q1
$304K Hold
1,713
0.18% 47
2021
Q4
$293K Buy
+1,713
New +$280K 0.19% 52

Other funds holding JNJ

Seldon Capital's JNJ Position: Q1 2026 in Review

Seldon Capital held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 1,713 shares worth $419K. The position accounts for 0.15% of the portfolio, ranked #44.

Seldon Capital first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $531K in Q1 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Seldon Capital held 1,713 shares of Johnson & Johnson worth $419K as of Q1 2026.
  • Seldon Capital left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.15% of Seldon Capital's portfolio in Q1 2026, its #44 holding.
  • Seldon Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Seldon Capital's Johnson & Johnson position peaked at $531K in Q1 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Seldon Capital's 13F filing for Q1 2026, filed 15 May 2026.